Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 8/20 | 0.59 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 8/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.59 |
| ▸ | DRD2 | P14416 | 2/20 | 0.52 |
| ▸ | DRD3 | P35462 | 2/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4761442 | 0.88 | SLC6A2 (0.68) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| SCHEMBL4557697 | 0.88 | SLC6A2 (0.68) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| SCHEMBL10819294 | 0.88 | SLC6A2 (0.68) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| SCHEMBL14520924 | 0.88 | SLC6A2 (0.68) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| SCHEMBL14520923 | 0.88 | SLC6A2 (0.68) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| Hydrochloric Acid SCHEMBL4326374 | 0.87 | SLC6A2 (0.66) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| SCHEMBL4713245 | 0.82 | KCNH2 (0.65) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| Hydrochloric Acid SCHEMBL11622067 | 0.81 | KCNH2 (0.64) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| SCHEMBL11083508 | 0.78 | SLC6A2 (0.59) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 | |
| SCHEMBL4711836 | 0.78 | SLC6A2 (0.68) | SLC6A2SLC6A4SLC6A3KCNH2DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1904059-A2 | METHOD FOR TREATING NERVOUS SYSTEM DISORDERS AND CONDITIONS | Wyeth a Corporation of the State of Delaware (US) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007013936-A2 | METHOD FOR TREATING NERVOUS SYSTEM DISORDERS AND CONDITIONS | WYETH (US) | 2007-02-01 | — | — | WO | disclosed |